Divis Laboratories News

Hyderabad-based pharmaceutical giant, Divi's Laboratories Limited, is grappling with a Goods and Service Tax (GST) demand notice amounting to Rs 164 crore, coupled with interest and penalties. Despite the setback, the company remains optimistic, expressing confidence that the order will not ...

The Indian stock market faced a challenging week, reversing its previous gains to close with a loss of 1% for the week ending October 20. The Nifty Bank experienced a more substantial decline of over 1%, while the Midcap Index recorded ...

Shares of large cap Pharmaceuticals sector stock, Divi's Laboratories Ltd witnessed marginal rise of 0.17% on BSE on July 3 as board of directors of the company declared August 11, 2023 as the record date for Rs 30/- per share dividend ...

5 stocks are currently trading near their 52-week low price. These stocks are Wipro, Tech Mahindra, Tata Power Company, Mphasis, Divi's Laboratories Ltd. Check key details below:{photo-feature} ...

Leading brokerage firm Geojit Financial has given buy rating to the stock of Divi's Laboratories Ltd for a target price of Rs 4006 apiece with a potential gain of 15%.{photo-feature} ...

Amid strong global cues, Indian indices in line with their Asian peers opened higher in trade on May 10, 2021 and continue to trade firm in the afternoon session. At the time of writing this report, Nifty was up 123 points ...

Brokerage Anand Rathi has a 'buy' recommendation on Divi's Laboratories Ltd. with a target price of Rs 4,095. "We remain positive on the stock given its strong market position, strength in API manufacturing, established long-term contract with customers and benefit from ...